Eye Drops and Diarrhea
- 23 July 1964
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 271 (4) , 197-199
- https://doi.org/10.1056/nejm196407232710408
Abstract
ECHOTHIOPHATE iodide (Phospholine iodide) is administered as eye drops principally for the control of intraocular pressure in glaucoma. When introduced into the conjunctival sac, it produces an intense and prolonged miosis. It is a long acting parasympathomimetic (cholinergic) agent owing to its potent inhibition of cholinesterase.1 In addition to the local effect in the eye, there is systemic absorption, which is sufficient to produce a measurable decrease in the acetylcholinesterase activity of the red blood cells.2 3 4 Although symptoms resulting from systemic absorption are unusual the effects of cholinergic stimulation such as diarrhea, intestinal cramps, vomiting and paresthesia have been reported. . . .Keywords
This publication has 5 references indexed in Scilit:
- THE REACTION OF ACETYLCHOLINE AND OTHER CARBOXYLIC ACID DERIVATIVES WITH HYDROXYLAMINE, AND ITS ANALYTICAL APPLICATIONPublished by Elsevier ,2021
- Observation of Dangerous Side-Effect of Phospholine Iodide in Glaucoma TherapyAmerican Journal of Ophthalmology, 1963
- Systemic Effects Produced by Echothiophate Iodide in Treatment of GlaucomaArchives of Ophthalmology (1950), 1963
- ANTIDOTES AND POTENTIATING AGENTS FOR PHOSPHOLINE IODIDE1960
- THE CEREBRAL DISTRIBUTIONS OF A TERTIARY AND A QUATERNARY ANTICHOLINESTERASE AGENT FOLLOWING INTRAVENOUS AND INTRAVENTRICULAR INJECTION1956